Susquehanna International Group, LLP Novavax Inc Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Novavax Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 144,940 shares of NVAX stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

144,940

Previous 250,951 42.24%

Holding current value

$1.97 Million

Previous $1.2 Million 52.96%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$3.89 - $20.97 $412,382 - $2.22 Million	-106,011 Reduced 42.24%	144,940 $1.83 Million
Q1 2024 May 07, 2024	BUY	$3.76 - $6.02 $802,429 - $1.28 Million	213,412 Added 568.51%	250,951 $1.2 Million
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $778,905 - $1.24 Million	-162,272 Reduced 81.21%	37,539 $180,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $886,593 - $1.27 Million	-130,190 Reduced 39.45%	199,811 $1.45 Million
Q2 2023 Aug 11, 2023	SELL	$6.67 - $9.52 $1.52 Million - $2.17 Million	-228,281 Reduced 40.89%	330,001 $2.45 Million
Q1 2023 May 16, 2023	BUY	$5.76 - $12.48 $2.2 Million - $4.77 Million	382,348 Added 217.32%	558,282 $3.87 Million
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $1.02 Million - $2.89 Million	115,358 Added 190.44%	175,934 $1.81 Million
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $4.41 Million - $18.4 Million	-242,224 Reduced 79.99%	60,576 $1.1 Million
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $37.3 Million - $77.4 Million	-1,028,318 Reduced 77.25%	302,800 $15.6 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $4.67 Million - $9.57 Million	66,946 Added 5.3%	1,331,118 $98 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $14.4 Million - $23.3 Million	-106,982 Reduced 7.8%	1,264,172 $181 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $125 Million - $190 Million	700,509 Added 104.45%	1,371,154 $284 Million
Q2 2021 Aug 11, 2021	BUY	$121.0 - $257.67 $21.2 Million - $45.1 Million	175,040 Added 35.32%	670,645 $142 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $84.1 Million - $238 Million	-744,342 Reduced 60.03%	495,605 $89.9 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $56.4 Million - $99.9 Million	715,863 Added 136.59%	1,239,947 $138 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $30.8 Million - $69.2 Million	387,417 Added 283.48%	524,084 $56.8 Million
Q2 2020 Aug 14, 2020	SELL	$13.86 - $83.61 $1.62 Million - $9.74 Million	-116,549 Reduced 46.03%	136,667 $11.4 Million
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $944,685 - $3.85 Million	240,378 Added 1872.39%	253,216 $3.44 Million
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $51,608 - $100,649	12,838 New	12,838 $64,000

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.06B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Novavax Inc Transaction History